Karauzum Irem, Karauzum Kurtulus, Acar Burak, Hanci Kaan, Bildirici Halil Ibrahim Ulas, Kilic Teoman, Ural Ertan
Kocaeli University Faculty of Medicine, Istanbul, Turkey.
Department of Cardiology, Biruni University, Istanbul, Turkey.
J Transl Int Med. 2021 Jul 9;9(2):123-130. doi: 10.2478/jtim-2021-0024. eCollection 2021 Jun.
Lymphocyte-to-monocyte ratio (LMR) has emerged as a new indirect marker of inflammation, which is associated with adverse outcomes in cardiovascular diseases. The aim of this study was to evaluate whether admission LMR is associated with contrast-induced nephropathy (CIN) in patients who underwent percutaneous coronary intervention for acute coronary syndrome (ACS).
A total of 873 patients were assessed. LMR was calculated via dividing lymphocyte count by monocyte count.
LMR was significantly lower in the with-CIN group. ROC analysis showed that the LMR ratios <2.52 predicted CIN development with sensitivity of 66.3% and specificity of 55.8%. Multivariate analysis showed that eGFR, admission glucose, and LMR were independent predictors of CIN in patients with ACS.
LMR is an easily accessible marker and could be used as a predictor of CIN in patients with ACS undergoing percutaneous coronary intervention.
淋巴细胞与单核细胞比值(LMR)已成为一种新的炎症间接标志物,与心血管疾病的不良预后相关。本研究旨在评估急性冠状动脉综合征(ACS)患者经皮冠状动脉介入治疗时入院时的LMR是否与造影剂肾病(CIN)相关。
共评估了873例患者。LMR通过淋巴细胞计数除以单核细胞计数计算得出。
CIN组的LMR显著更低。ROC分析显示,LMR比值<2.52预测CIN发生的敏感性为66.3%,特异性为55.8%。多变量分析显示,估算肾小球滤过率(eGFR)、入院时血糖和LMR是ACS患者CIN的独立预测因素。
LMR是一种易于获取的标志物,可作为接受经皮冠状动脉介入治疗的ACS患者CIN的预测指标。